A multicountry evaluation of care HPV testing, visual inspection with acetic acid, and Papanicolaou testing for the detection of cervical cancer

International Journal of Gynecological Cancer

Volumn 24, Issue 3, 2014, Pages 576-585

  Jeronimo, Jose ^a   Bansil, Pooja ^a   Lim, Jeanette ^a   Peck, Roger ^a   Paul, Proma ^a   Amador, Juan Jose ^b   Mirembe, Florence ^c   Byamugisha, Josaphat ^d   Poli, Usha Rani ^e   Satyanarayana, Labani ^f   Asthana, Smita ^f  

^a PATH   (United States)

^b PATH   (Uganda)

^c MAKERERE UNIVERSITY   (Uganda)

^d MULAGO HOSPITAL   (Uganda)

^e Regional Cancer Center   (India)

^f INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

Cancer prevention and control; Cervical cancer; Early detection; HPV; Low resource settings

Indexed keywords

ACETIC ACID; VIRUS DNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURGERY; COLPOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HYSTERECTOMY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; DEVELOPING COUNTRY; DIAGNOSTIC USE; ISOLATION AND PURIFICATION; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ACETIC ACID; ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DEVELOPING COUNTRIES; DNA, VIRAL; FEASIBILITY STUDIES; FEMALE; HUMANS; PAPANICOLAOU TEST; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84899586979     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000084     Document Type: Article

References (26)

1. Ferlay J, Shin HR, Bray F, et al. Globocan 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10. [Globocan Web site] 2010. Available at: http://globocan.iarc.fr/. Accessed April 2, 2013.
2. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention: Cervix Cancer Screening. Lyon, France: IARC Press; 2005.
3. Munñz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in youngwomen. J Natl Cancer Inst. 2010;102:325-339.
4. Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:89-99.
5. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101.
6. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579-1588.
7. Naucler P, Ryd W, Tornberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical caner. N Engl J Med. 2007;357:1589-1597.
8. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360:1385-1394.
9. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11:249-257.
10. Rijkaart DC, Berkhof J, Rozendaal L, et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012;13:78-88.
11. Ferreccio C, Barriga MI, Lagos M, et al. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile. Int J Cancer. 2013;132:916-923.
12. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
13. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743-753.
14. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-1927.
15. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928-1943.
16. Chen C, Yang Z, Li Z, et al. Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis. Int J Gynecol Cancer. 2012;22:908-921.
17. Sritipsukho P, Thaweekul Y. Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review. J Med Assoc Thai. 2010;93:S254YS261.
18. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370:398-406.
19. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:368-383.
20. Denny L, Kuhn L, Hu CC, et al. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst. 2010;102:1557-1567.
21. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929-936.
22. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst. 2012;104:178-188.
23. Snijders PJ, Verhoef VM, Arbyn M, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer. 2013;132:2223-2236.
24. Sellors J, Camacho Carr K, Bingham A, et al. Course in Visual Methods for Cervical Cancer Screening: Visual Inspection with Acetic Acid and Lugol's Iodine. Seattle, WA: PATH; 2004.
25. Sauvaget C, Fayette JM, Muwonge R, et al. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011;113:14-24.
26. Maucort-Boulch D, Franceschi S, Plummer M. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev. 2008;17:717-720.